Site map Print
Pharmaceuticals and Healthcare
The practice

As a response to the growth of the domestic pharmaceutical market, including the advance of Russian companies as well as international players, Egorov Puginsky Afanasiev & Partners have set up a practice dedicated to the legal support of pharmaceutical companies. The pharma industry is attracting an increasing amount of attention from the state, which is evident from the growing number of statutory acts regulating the industry, as well as more elaborate strategies to stimulate national production of pharmaceuticals (e.g. Pharma 2020).

Our experience of working with major Russian and foreign pharmaceutical companies allows us to utilize the unique skill-set of our specialists to form teams capable of executing assignments of the broadest nature and complexity.

One of the key capabilities of the practice is the legal assistance in conducting internal investigations to identify risks of violations of Russian legislation on the fight against corruption, as well as the relevant provisions of the law of foreign countries, particularly the US (FCPA) and the UK (UK Anti-Bribery Act).

Services

As part of an integrated service for companies in the pharmaceutical and healthcare sectors, Egorov Puginsky Afanasiev & Partners provides, inter alia, the following services:

  • due diligence of companies to identify existing and potential legal risks, as well as recommendations on minimizing risks following the due diligence results;
  • drafting documents required for the operation of pharmaceutical companies;
  • development and implementation of required internal policies, including anti-corruption and compliance procedures, as well as compliance with the regulator and prevention of conflicts of interest when doing business in the Russian Federation and within the Customs Union (CIS); 
  • extensive support in dealing with intellectual property issues arising out of doing business in the pharmaceutical sphere;
  • extensive support in relation to antitrust regulation, including the representation of the interests of pharmaceutical companies in investigations and examinations of cases of violation of the antimonopoly legislation;
  • extensive support in issues related to public procurement of drugs;
  • consultation and preparation of legal opinions on specific to pharma sector legislation;
  • legal support of pharmaceutical companies in court proceedings and representation in disputes related to the conduct of the pharmaceutical business.

Key contacts

Andrew
Mac

Washington

 

EPAM EMAIL UPDATES

Sectors *
Type(s) of email updates you are interested in *
Jurisdiction(s) you are interested in *
Practice area(s) you are interested in *
* Required fields

RSS

News
Media Coverage
Legal Updates
Rankings and Awards